JP2006520767A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006520767A5 JP2006520767A5 JP2006505152A JP2006505152A JP2006520767A5 JP 2006520767 A5 JP2006520767 A5 JP 2006520767A5 JP 2006505152 A JP2006505152 A JP 2006505152A JP 2006505152 A JP2006505152 A JP 2006505152A JP 2006520767 A5 JP2006520767 A5 JP 2006520767A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cancer
- disease
- prevention
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 230000004770 neurodegeneration Effects 0.000 claims 2
- 208000015122 neurodegenerative disease Diseases 0.000 claims 2
- 201000004384 Alopecia Diseases 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000004736 B-Cell Leukemia Diseases 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000010412 Glaucoma Diseases 0.000 claims 1
- 102000019058 Glycogen Synthase Kinase 3 beta Human genes 0.000 claims 1
- 108010051975 Glycogen Synthase Kinase 3 beta Proteins 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000017442 Retinal disease Diseases 0.000 claims 1
- 206010038923 Retinopathy Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000000389 T-cell leukemia Diseases 0.000 claims 1
- 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 claims 1
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 1
- 201000004810 Vascular dementia Diseases 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 231100000360 alopecia Toxicity 0.000 claims 1
- 208000028683 bipolar I disease Diseases 0.000 claims 1
- 208000029028 brain injury Diseases 0.000 claims 1
- 208000026106 cerebrovascular disease Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- 208000020431 spinal cord injury Diseases 0.000 claims 1
- 201000002510 thyroid cancer Diseases 0.000 claims 1
- 230000000472 traumatic effect Effects 0.000 claims 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
- LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical compound BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 5
- 239000000463 material Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XWCQSILTDPAWDP-MRVPVSSYSA-N (1s)-2-chloro-1-phenylethanol Chemical compound ClC[C@@H](O)C1=CC=CC=C1 XWCQSILTDPAWDP-MRVPVSSYSA-N 0.000 description 1
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 1
- -1 9- [2- (3-Bromo-phenyl) -2-hydroxy-ethyl] -2,8-dipyridin-4-yl-6,7,8,9-tetrahydro-pyrimido [1,2-a] pyrimidine- 4-on 2-bromoacetophenone Chemical compound 0.000 description 1
- RCYKTASSXMMFJH-UHFFFAOYSA-N 9-(2-hydroxy-2-phenylethyl)-2,8-dipyridin-4-yl-7,8-dihydro-6h-pyrimido[1,2-a]pyrimidin-4-one;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(O)CN1C(C=2C=CN=CC=2)CCN(C(C=2)=O)C1=NC=2C1=CC=NC=C1 RCYKTASSXMMFJH-UHFFFAOYSA-N 0.000 description 1
- IXPJREYPJDQKQH-UHFFFAOYSA-N 9-[2-(3-bromophenyl)-2-oxoethyl]-2,8-dipyridin-4-yl-7,8-dihydro-6h-pyrimido[1,2-a]pyrimidin-4-one;hydrochloride Chemical compound Cl.BrC1=CC=CC(C(=O)CN2C=3N(C(C=C(N=3)C=3C=CN=CC=3)=O)CCC2C=2C=CN=CC=2)=C1 IXPJREYPJDQKQH-UHFFFAOYSA-N 0.000 description 1
- JDCQTKYKKRQEDI-UHFFFAOYSA-N Cl.FC=1C=C(C=CC1)C(CN1C(CCN2C1=NC(=CC2=O)C2=CC=NC=C2)C2=CC=NC=C2)=O Chemical compound Cl.FC=1C=C(C=CC1)C(CN1C(CCN2C1=NC(=CC2=O)C2=CC=NC=C2)C2=CC=NC=C2)=O JDCQTKYKKRQEDI-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03290727A EP1460075A1 (en) | 2003-03-21 | 2003-03-21 | Substituted 8-Pyridinyl-6,7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 8-Phenyl-6-7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one derivatives |
| PCT/EP2004/004014 WO2004082577A2 (en) | 2003-03-21 | 2004-03-19 | 8-SUBSTITUTED-6, 7, 8, 9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006520767A JP2006520767A (ja) | 2006-09-14 |
| JP2006520767A5 true JP2006520767A5 (enExample) | 2007-05-10 |
| JP4572195B2 JP4572195B2 (ja) | 2010-10-27 |
Family
ID=32799140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006505152A Expired - Fee Related JP4572195B2 (ja) | 2003-03-21 | 2004-03-19 | ８−置換−６，７，８，９−テトラヒドロピリミド［１，２−ａ］ピリミジン−４−オン誘導体 |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7247638B2 (enExample) |
| EP (2) | EP1460075A1 (enExample) |
| JP (1) | JP4572195B2 (enExample) |
| KR (1) | KR101070149B1 (enExample) |
| CN (1) | CN100358897C (enExample) |
| AR (1) | AR043658A1 (enExample) |
| AT (1) | ATE452892T1 (enExample) |
| AU (1) | AU2004222596B2 (enExample) |
| BR (1) | BRPI0408591A (enExample) |
| CA (1) | CA2518299C (enExample) |
| CY (1) | CY1109890T1 (enExample) |
| DE (1) | DE602004024770D1 (enExample) |
| DK (1) | DK1608654T3 (enExample) |
| EA (1) | EA009197B1 (enExample) |
| ES (1) | ES2338325T3 (enExample) |
| IL (1) | IL170680A (enExample) |
| MX (1) | MXPA05010158A (enExample) |
| NO (1) | NO20054330L (enExample) |
| NZ (1) | NZ542380A (enExample) |
| PL (1) | PL1608654T3 (enExample) |
| PT (1) | PT1608654E (enExample) |
| SI (1) | SI1608654T1 (enExample) |
| TW (1) | TWI330186B (enExample) |
| WO (1) | WO2004082577A2 (enExample) |
| ZA (1) | ZA200507487B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1460075A1 (en) * | 2003-03-21 | 2004-09-22 | Sanofi-Synthelabo | Substituted 8-Pyridinyl-6,7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 8-Phenyl-6-7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one derivatives |
| BRPI0715160A2 (pt) | 2006-08-08 | 2013-06-11 | Sanofi Aventis | imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso |
| EP1939187A1 (en) * | 2006-12-20 | 2008-07-02 | Sanofi-Aventis | Substituted heteroaryl pyridopyrimidone derivatives |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| ES2443016T3 (es) | 2009-08-26 | 2014-02-17 | Sanofi | Nuevos hidratos cristalinos de fluoroglicósidos heteroaromáticos, productos farmacéuticos que comprenden estos compuestos, y su empleo |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| EP2683701B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683702B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2683698B1 (de) | 2011-03-08 | 2017-10-04 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| US8895547B2 (en) | 2011-03-08 | 2014-11-25 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| TWI838401B (zh) | 2018-09-12 | 2024-04-11 | 瑞士商諾華公司 | 抗病毒性吡啶并吡𠯤二酮化合物 |
| TWI867053B (zh) | 2019-09-26 | 2024-12-21 | 瑞士商諾華公司 | 抗病毒吡唑并吡啶酮化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001270884A (ja) * | 2000-03-23 | 2001-10-02 | Mitsubishi-Tokyo Pharmaceuticals Inc | ピリミドン誘導体 |
| EP1136482A1 (en) * | 2000-03-23 | 2001-09-26 | Sanofi-Synthelabo | 2-Amino-3-(alkyl)-pyrimidone derivatives as GSK3beta inhibitors |
| ATE269333T1 (de) * | 2000-09-01 | 2004-07-15 | Sanofi Synthelabo | 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2- a)pyrimidin-4-on- und 7-pyridinyl-2,3- dihydroimidazo(1,2-a)pyrimidin-5 1honderivate |
| EP1184383A1 (en) * | 2000-09-01 | 2002-03-06 | Sanofi-Synthelabo | 9-[Alkyl], 9-[(heteroaryl)alkyl] and 9-[(aryl)alkyl]-2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives |
| EP1460075A1 (en) * | 2003-03-21 | 2004-09-22 | Sanofi-Synthelabo | Substituted 8-Pyridinyl-6,7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 8-Phenyl-6-7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one derivatives |
-
2003
- 2003-03-21 EP EP03290727A patent/EP1460075A1/en not_active Withdrawn
-
2004
- 2004-03-17 TW TW093107079A patent/TWI330186B/zh not_active IP Right Cessation
- 2004-03-19 DE DE602004024770T patent/DE602004024770D1/de not_active Expired - Lifetime
- 2004-03-19 WO PCT/EP2004/004014 patent/WO2004082577A2/en not_active Ceased
- 2004-03-19 DK DK04721906.8T patent/DK1608654T3/da active
- 2004-03-19 ZA ZA200507487A patent/ZA200507487B/en unknown
- 2004-03-19 EA EA200501315A patent/EA009197B1/ru not_active IP Right Cessation
- 2004-03-19 AU AU2004222596A patent/AU2004222596B2/en not_active Ceased
- 2004-03-19 MX MXPA05010158A patent/MXPA05010158A/es active IP Right Grant
- 2004-03-19 PL PL04721906T patent/PL1608654T3/pl unknown
- 2004-03-19 AR ARP040100917A patent/AR043658A1/es unknown
- 2004-03-19 AT AT04721906T patent/ATE452892T1/de active
- 2004-03-19 PT PT04721906T patent/PT1608654E/pt unknown
- 2004-03-19 KR KR1020057017572A patent/KR101070149B1/ko not_active Expired - Fee Related
- 2004-03-19 NZ NZ542380A patent/NZ542380A/en not_active IP Right Cessation
- 2004-03-19 EP EP04721906A patent/EP1608654B1/en not_active Expired - Lifetime
- 2004-03-19 SI SI200431367T patent/SI1608654T1/sl unknown
- 2004-03-19 ES ES04721906T patent/ES2338325T3/es not_active Expired - Lifetime
- 2004-03-19 JP JP2006505152A patent/JP4572195B2/ja not_active Expired - Fee Related
- 2004-03-19 CA CA2518299A patent/CA2518299C/en not_active Expired - Fee Related
- 2004-03-19 BR BRPI0408591-4A patent/BRPI0408591A/pt not_active IP Right Cessation
- 2004-03-19 CN CNB2004800120116A patent/CN100358897C/zh not_active Expired - Fee Related
-
2005
- 2005-09-05 IL IL170680A patent/IL170680A/en not_active IP Right Cessation
- 2005-09-13 US US11/225,218 patent/US7247638B2/en not_active Expired - Fee Related
- 2005-09-20 NO NO20054330A patent/NO20054330L/no not_active Application Discontinuation
-
2007
- 2007-06-18 US US11/764,374 patent/US8093256B2/en not_active Expired - Fee Related
-
2010
- 2010-03-09 CY CY20101100221T patent/CY1109890T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006520767A5 (enExample) | ||
| JP2006520766A5 (enExample) | ||
| RU2659779C2 (ru) | Замещенные соединения тиофен- и фуран-конденсированного азолопиримидин-5-(6н)-она | |
| JP4572195B2 (ja) | ８−置換−６，７，８，９−テトラヒドロピリミド［１，２−ａ］ピリミジン−４−オン誘導体 | |
| DE60206946T2 (de) | Substituierte 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on- und 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)onderivate gegen neurodegenerative erkrankungen | |
| JP2006519814A5 (enExample) | ||
| DE60205921T2 (de) | SUBSTITUIERTE 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDOç1,2-A!PYRIMIDIN-4-ON- UND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO-ç1,2-A!PYRIMIDIN-5(1H)ONDERIVATE | |
| JP2010538001A5 (enExample) | ||
| AU2007311983B2 (en) | An Alzheimer' s disease progression inhibitor containing heterocyclic compound | |
| JP2010526138A (ja) | ピロロピリミジン−７−オン誘導体とその薬剤としての使用 | |
| RU2007119585A (ru) | Производные рапамицина и их применение при лечении неврологических заболеваний | |
| JP2004538268A5 (enExample) | ||
| DE602004006869T2 (de) | 5ht2c rezeptor agonisten zur behandlung von diabetes und fettleibigkeit | |
| WO2006033007A3 (en) | Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one | |
| MXPA04007147A (es) | Aza-arilpiperazinas. | |
| CA2516937A1 (en) | Substituted 8'-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a]pyrimidin-6-one and 8'-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a]pyrimidin-6-one derivatives and theiruse against neurogenerative diseases | |
| JP2005504810A5 (enExample) | ||
| EP1637533A1 (de) | Substituierte Thiazolopyrimidine als Analgetika | |
| WO2005044818A2 (en) | Imidazo[1,2-a]pyridine anxiolytics | |
| JP2007520525A5 (enExample) | ||
| JP6268656B2 (ja) | ヒト免疫不全ウイルス複製の阻害剤 | |
| JP2006519813A5 (enExample) | ||
| CA2445834A1 (en) | Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands | |
| US20240182436A1 (en) | Substituted sulfonamide-chroman compounds, and pharmaceutical compositions, and methods of use thereof | |
| WO2021123798A1 (en) | 1h-pyrazolo[3,4-d]pyrimidine compounds useful for the treatment of platinum-resistant cancer |